Evidence map›Paper›PMID 26363057›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Cutting Edge: The Orphan Nuclear Receptor Nr4a1 Regulates CD8+ T Cell Expansion and Effector Function through Direct Repression of Irf4.

Heba N Nowyhed, Tridu R Huynh, Graham D Thomas, Amy Blatchley, Catherine C Hedrick

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 50 citations in OpenAlex.

  1. Interferon regulatory factors orchestrate CD8International journal of molecular medicine · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. NR4A1 limits CD8Research square · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. The precursors of CD8Nature reviews. Immunology · 2022
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Early programming of CD8Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  18. Nur77 controls tolerance induction, terminal differentiation, and effector functions in semi-invariant natural killer T cells.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  19. Article
  20. Discipline in Stages: Regulating CD8Frontiers in immunology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Heba N NowyhedDivision of Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.
Tridu R HuynhDivision of Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.
Graham D ThomasDivision of Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.
Amy BlatchleyDivision of Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.
Catherine C HedrickDivision of Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037 hedrick@lji.org.
La Jolla Institute for Immunology · US

Funding

ROLE OF LIPOXYGENASES IN ATHEROGENESIS IN DIABETES MELLITUSP01HL055798 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HEDRICK, CATHERINE C · 1995 to 2016
$28.4M
Nuclear Receptors in Myeloid Development, Inflammation, and AtherosclerosisR01HL118765 · NHLBI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI HEDRICK, CATHERINE C · 2013 to 2016
$2.2M
Role of ABCA7 in iNKT development and function and its impact on atherosclerosisF32HL117533 · NHLBI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI NOWYHED, HEBA · 2013 to 2015
$136k
NHLBI NIH HHS F32 HL117533NHLBI NIH HHS F32HL117533-02NHLBI NIH HHS P01 HL055798NHLBI NIH HHS P01HL055798NHLBI NIH HHS R01 HL118765NHLBI NIH HHS R01HL118765
6 · The paper itself

Abstract

The transcription factor IFN regulatory factor (IRF)4 was shown to play a crucial role in the protective CD8(+) T cell response; however, regulation of IRF4 expression in CD8(+) T cells remains unclear. In this article, we report a critical role for Nr4a1 in regulating the expansion, differentiation, and function of CD8(+) T cells through direct transcriptional repression of Irf4. Without Nr4a1, the regulation of IRF4 is lost, driving an increase in Irf4 expression and, in turn, resulting in a faster rate of CD8 T cell proliferation and expansion. Nr4a1-deficient mice show increases in CD8 T cell effector responses with improved clearance of Listeria monocytogenes. Our data support a novel and critical role for Nr4a1 in the regulation of CD8(+) T cell expansion and effector function through transcriptional repression of Irf4.

Indexed as

Cell ProliferationAnimalsCD8-Positive T-LymphocytesCell DifferentiationInterferon Regulatory Factor-4Interferon Regulatory FactorsListeria monocytogenesListeriosisMiceMice, KnockoutNuclear Receptor Subfamily 4, Group A, Member 1Interferon Regulatory Factor-4Interferon Regulatory FactorsNr4a1 protein, mouseNuclear Receptor Subfamily 4, Group A, Member 1

Identifiers

PMID26363057
PMCPMC4592102
OpenAlexW2177542033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.